Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02494869 · ClinicalTrials.gov registry record · NA
Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer
A NA study of High Risk for Developing Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT02494869: Active NA study of High Risk for Developing Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02494869 is a NA study of High Risk for Developing Breast Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02494869, a NA study of High Risk for Developing Breast Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to look at the effect that different amounts of progressive exercise training has on risk factors associated with developing breast cancer. These risk factors include exercise capacity, body weight, and body composition, as well as the expression of certain genes and levels of inflammatory factors in your breast tissue. The participant will be instructed to self-report the session information to ExOnc staff at or before their next scheduled visit. If the participant's next scheduled visit is greater than 72 hours following an unsupervised session, ExOnc staff may reach out to the participant to retrieve the session information. Unsupervised session details will be source documented by ExOnc staff.
Primary Outcome
Fresh-frozen tissue sections from normal breast epithelial cell samples before and after aerobic training will be cut and stained using hematoxylin \& eosin, and the morphological features will be reviewed.
Conditions Studied
Interventions
- OTHER Blood draw
- BEHAVIORAL Nonlinear Aerobic Training
- OTHER Height, Weight, BMI measure
- OTHER Cardiopulmonary exercise test
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2015-07 |
| Est. Completion | 2026-07 |
| Phase | NA |
What the registry record for NCT02494869 still lists
NCT02494869 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with High Risk for Developing Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which Blood draw is the first listed.
NCT02494869 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02494869 about?
NCT02494869 is a clinical study titled "Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer". This study is being done to look at the effect that different amounts of progressive exercise training has on risk factors associated with developing breast cancer. These risk factors include exercise capacity, body weight, and body composition, as well as the expression of certain genes and levels ...
What is the current status of trial NCT02494869?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2015-07. Estimated completion is 2026-07.
What conditions does trial NCT02494869 study?
This clinical trial studies the following conditions: High Risk for Developing Breast Cancer.
What interventions are being tested in trial NCT02494869?
The interventions under investigation include: Blood draw (OTHER), Nonlinear Aerobic Training (BEHAVIORAL), Height, Weight, BMI measure (OTHER), Cardiopulmonary exercise test (OTHER).
Who is sponsoring clinical trial NCT02494869?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02494869 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02494869's enrollment target sits among peer trials
75 1069th of 2000 higher than 919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia